Related references
Note: Only part of the references are listed.Genetic engineering of T cells for immunotherapy
Gavin I. Ellis et al.
NATURE REVIEWS GENETICS (2021)
Promises and challenges of adoptive T-cell therapies for solid tumours
Matteo Morotti et al.
BRITISH JOURNAL OF CANCER (2021)
A CRISPR Screen Reveals Resistance Mechanisms to CD3-Bispecific Antibody Therapy
Si-Qi Liu et al.
CANCER IMMUNOLOGY RESEARCH (2021)
Translating gammadelta (gamma delta) T cells and their receptors into cancer cell therapies
Zsolt Sebestyen et al.
NATURE REVIEWS DRUG DISCOVERY (2020)
CRISPR-engineered T cells in patients with refractory cancer
Edward A. Stadtmauer et al.
SCIENCE (2020)
T-cell receptor affinity in the age of cancer immunotherapy
Michele M. Hoffmann et al.
MOLECULAR CARCINOGENESIS (2020)
KTE-X19 CAR T-Cell Therapy in Relapsed or Refractory Mantle-Cell Lymphoma
Michael Wang et al.
NEW ENGLAND JOURNAL OF MEDICINE (2020)
CRISPR/Cas systems to overcome challenges in developing the next generation of T cells for cancer therapy
Dennis Huang et al.
ADVANCED DRUG DELIVERY REVIEWS (2020)
Economic Evaluation of Chimeric Antigen Receptor T-Cell Therapy by Site of Care Among Patients With Relapsed or Refractory Large B-Cell Lymphoma
Gary H. Lyman et al.
JAMA NETWORK OPEN (2020)
Overexpression of Mesothelin in Pancreatic Ductal Adenocarcinoma (PDAC)
Kai Le et al.
INTERNATIONAL JOURNAL OF MEDICAL SCIENCES (2020)
Facing the future: challenges and opportunities in adoptive T cell therapy in cancer
Isabelle Magalhaes et al.
EXPERT OPINION ON BIOLOGICAL THERAPY (2019)
MAGE cancer-testis antigens protect the mammalian germline under environmental stress
Klementina Fon Tacer et al.
SCIENCE ADVANCES (2019)
T cell receptor-based cancer immunotherapy: Emerging efficacy and pathways of resistance
Smita S. Chandran et al.
IMMUNOLOGICAL REVIEWS (2019)
T-Cell Receptor Gene Therapy for Human Papillomavirus-Associated Epithelial Cancers: A First-in-Human, Phase I/II Study
Stacey L. Doran et al.
JOURNAL OF CLINICAL ONCOLOGY (2019)
Tumor neoantigens: from basic research to clinical applications
Tao Jiang et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
Tissue Expression of Melanoma-associated Antigen A6 and Clinical Characteristics of Gastric Cancer
Miyo Endo et al.
ANTICANCER RESEARCH (2019)
MAGE-A1 in lung adenocarcinoma as a promising target of chimeric antigen receptor T cells
Yuan Mao et al.
JOURNAL OF HEMATOLOGY & ONCOLOGY (2019)
TCR Fingerprinting and Off-Target Peptide Identification
Armen R. Karapetyan et al.
FRONTIERS IN IMMUNOLOGY (2019)
Systemic and local immunity following adoptive transfer of NY-ESO-1 SPEAR T cells in synovial sarcoma
Indu Ramachandran et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2019)
ASTCT Consensus Grading for Cytokine Release Syndrome and Neurologic Toxicity Associated with Immune Effector Cells
Daniel W. Lee et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2019)
Recent advances in CAR T-cell toxicity: Mechanisms, manifestations and management
Jennifer N. Brudno et al.
BLOOD REVIEWS (2019)
Streamlined production of genetically modified T cells with activation, transduction and expansion in closed-system G-Rex bioreactors
Christine Gagliardi et al.
CYTOTHERAPY (2019)
Long-term safety and activity of axicabtagene ciloleucel in refractory large B-cell lymphoma (ZUMA-1): a single-arm, multicentre, phase 1-2 trial
Frederick L. Locke et al.
LANCET ONCOLOGY (2019)
Tisagenlecleucel in Adult Relapsed or Refractory Diffuse Large B-Cell Lymphoma
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2019)
Patient HLA class I genotype influences cancer response to checkpoint blockade immunotherapy
Diego Chowell et al.
SCIENCE (2018)
T-cell receptor-engineered T cells for cancer treatment: current status and future directions
Yu Ping et al.
PROTEIN & CELL (2018)
Prospective Analysis of Adoptive TIL Therapy in Patients with Metastatic Melanoma: Response, Impact of Anti-CTLA4, and Biomarkers to Predict Clinical Outcome
Marie-Andree Forget et al.
CLINICAL CANCER RESEARCH (2018)
Chimeric Antigen Receptor Therapy
Carl H. June et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Tisagenlecleucel in Children and Young Adults with B-Cell Lymphoblastic Leukemia
S. L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Antitumor Activity Associated with Prolonged Persistence of Adoptively Transferred NY-ESO-1c259 T Cells in Synovial Sarcoma
Sandra P. D'Angelo et al.
CANCER DISCOVERY (2018)
Engineering Approaches in Human Gamma Delta T Cells for Cancer Immunotherapy
Jonathan Fisher et al.
FRONTIERS IN IMMUNOLOGY (2018)
T cell receptor fingerprinting enables in-death characterization of the interactions governing recognition of peptide-MHC complexes
Amalie K. Bentzen et al.
NATURE BIOTECHNOLOGY (2018)
Enhancing CAR T cell persistence through ICOS and 4-1BB costimulation
Sonia Guedan et al.
JCI INSIGHT (2018)
NY-ESO-1 expression predicts an aggressive phenotype of ovarian cancer
J. Brian Szender et al.
GYNECOLOGIC ONCOLOGY (2017)
Engineering Natural Killer Cells for Cancer Immunotherapy
Katayoun Rezvani et al.
MOLECULAR THERAPY (2017)
Therapeutic T cell engineering
Michel Sadelain et al.
NATURE (2017)
Chimeric Antigen Receptor T Cells in Refractory B-Cell Lymphomas
Stephen J. Schuster et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Axicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
S. S. Neelapu et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Overcoming the Immunosuppressive Tumor Microenvironment of Hodgkin Lymphoma Using Chimeric Antigen Receptor T Cells
Marco Ruella et al.
CANCER DISCOVERY (2017)
Comprehensive immunohistochemical study of mesothelin (MSLN) using different monoclonal antibodies 5B2 and MN-1 in 1562 tumors with evaluation of its prognostic value in malignant pleural mesothelioma
Shingo Inaguma et al.
ONCOTARGET (2017)
Targeting neoantigens to augment antitumour immunity
Mark Yarchoan et al.
NATURE REVIEWS CANCER (2017)
Cytokine-Induced Memory-Like Differentiation Enhances Unlicensed Natural Killer Cell Antileukemia and FcγRIIIa-Triggered Responses
Julia A. Wagner et al.
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION (2017)
Mesothelin as a biomarker for ovarian carcinoma: a meta-analysis
Kristian Madeira et al.
ANAIS DA ACADEMIA BRASILEIRA DE CIENCIAS (2016)
Long-Lasting Complete Responses in Patients with Metastatic Melanoma after Adoptive Cell Therapy with Tumor-Infiltrating Lymphocytes and an Attenuated IL2 Regimen
Rikke Andersen et al.
CLINICAL CANCER RESEARCH (2016)
The urgent need to recover MHC class I in cancers for effective immunotherapy
Federico Garrido et al.
CURRENT OPINION IN IMMUNOLOGY (2016)
Targeted antibody-mediated depletion of murine CD19 CAR T cells permanently reverses B cell aplasia
Paulina J. Paszkiewicz et al.
JOURNAL OF CLINICAL INVESTIGATION (2016)
TCR-engineered T cells to treat tumors: Seeing but not touching?
Reno Debets et al.
SEMINARS IN IMMUNOLOGY (2016)
Personalized fludarabine dosing to reduce nonrelapse mortality in hematopoietic stem-cell transplant recipients receiving reduced intensity conditioning
Kinjal Sanghavi et al.
TRANSLATIONAL RESEARCH (2016)
Adoptive T Cell Therapies: A Comparison of T Cell Receptors and Chimeric Antigen Receptors
Daniel T. Harris et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2016)
Consequences of point mutations in melanoma-associated antigen 4 (MAGE-A4) protein: Insights from structural and biophysical studies
Yoshio Hagiwara et al.
SCIENTIFIC REPORTS (2016)
Structures of Two Melanoma-Associated Antigens Suggest Allosteric Regulation of Effector Binding
Joseph A. Newman et al.
PLOS ONE (2016)
Histone H3F3A and HIST1H3B K27M mutations define two subgroups of diffuse intrinsic pontine gliomas with different prognosis and phenotypes
David Castel et al.
ACTA NEUROPATHOLOGICA (2015)
The melanoma-associated antigen 1 (MAGEA1) protein stimulates the E3 ubiquitin-ligase activity of TRIM31 within a TRIM31-MAGEA1-NSE4 complex
Lucie Kozakova et al.
CELL CYCLE (2015)
Complete Regression of Metastatic Cervical Cancer After Treatment With Human Papillomavirus-Targeted Tumor-Infiltrating T Cells
Sanja Stevanovic et al.
JOURNAL OF CLINICAL ONCOLOGY (2015)
NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma
Aaron P. Rapoport et al.
NATURE MEDICINE (2015)
Adoptive cell transfer as personalized immunotherapy for human cancer
Steven A. Rosenberg et al.
SCIENCE (2015)
Neoantigens in cancer immunotherapy
Ton N. Schumacher et al.
SCIENCE (2015)
T cell metabolic fitness in antitumor immunity
Peter J. Siska et al.
TRENDS IN IMMUNOLOGY (2015)
Convergence of Acquired Mutations and Alternative Splicing of CD19 Enables Resistance to CART-19 Immunotherapy
Elena Sotillo et al.
CANCER DISCOVERY (2015)
Natural Killer Cell-Based Therapies Targeting Cancer: Possible Strategies to Gain and Sustain Anti-Tumor Activity
Carin I. M. Dahlberg et al.
FRONTIERS IN IMMUNOLOGY (2015)
Intrathecal trastuzumab: immunotherapy improves the prognosis of leptomeningeal metastases in HER-2+ breast cancer patient
Nu T. Lu et al.
JOURNAL FOR IMMUNOTHERAPY OF CANCER (2015)
A Pilot Trial Using Lymphocytes Genetically Engineered with an NY-ESO-1-Reactive T-cell Receptor: Long-term Follow-up and Correlates with Response
Paul F. Robbins et al.
CLINICAL CANCER RESEARCH (2015)
The TCR's sensitivity to self peptide-MHC dictates the ability of naive CD8+ T cells to respond to foreign antigens
Ross B. Fulton et al.
NATURE IMMUNOLOGY (2015)
γδ T Cells: First Line of Defense and Beyond
Yueh-hsiu Chien et al.
ANNUAL REVIEW OF IMMUNOLOGY, VOL 32 (2014)
The association between Histone 3 Lysine 27 Trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters
Marjolaine Ngollo et al.
BMC CANCER (2014)
Neuroblastoma Killing Properties of Vδ2 and Vδ2-Negative γδT Cells Following Expansion by Artificial Antigen-Presenting Cells
Jonathan P. H. Fisher et al.
CLINICAL CANCER RESEARCH (2014)
Opportunities and limitations of natural killer cells as adoptive therapy for malignant disease
James O. J. Davies et al.
CYTOTHERAPY (2014)
TALEN-mediated editing of endogenous T-cell receptors facilitates efficient reprogramming of T lymphocytes by lentiviral gene transfer
B. Berdien et al.
GENE THERAPY (2014)
Expression of New York esophageal squamous cell carcinoma-1 in primary and metastatic melanoma
Phyu P. Aung et al.
HUMAN PATHOLOGY (2014)
Re-adapting T cells for cancer therapy: from mouse models to clinical trials
Ingunn M. Stromnes et al.
IMMUNOLOGICAL REVIEWS (2014)
TCR repertoires of intratumoral T-cell subsets
Carsten Linnemann et al.
IMMUNOLOGICAL REVIEWS (2014)
Expression of MAGE-A3/6 in Primary Breast Cancer is Associated With Hormone Receptor Negative Status, High Histologic Grade, and Poor Survival
Maha Ayyoub et al.
JOURNAL OF IMMUNOTHERAPY (2014)
Chimeric Antigen Receptor T Cells for Sustained Remissions in Leukemia
Shannon L. Maude et al.
NEW ENGLAND JOURNAL OF MEDICINE (2014)
Human Adenovirus-Specific γ/δ and CD8+ T Cells Generated by T-Cell Receptor Transfection to Treat Adenovirus Infection after Allogeneic Stem Cell Transplantation
Jan Doerrie et al.
PLOS ONE (2014)
Molecular architecture of the αβ T cell receptor-CD3 complex
Michael E. Birnbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2014)
Elevated PRAME expression: what does this mean for treatment of head and neck squamous cell carcinoma?
Miroslaw J. Szczepanski et al.
BIOMARKERS IN MEDICINE (2013)
Full screening and accurate subtyping of HLA-A*02 alleles through group-specific amplification and mono-allelic sequencing
Shengli Song et al.
CELLULAR & MOLECULAR IMMUNOLOGY (2013)
Adoptive Transfer of Tumor-Infiltrating Lymphocytes in Patients with Metastatic Melanoma: Intent-to-Treat Analysis and Efficacy after Failure to Prior Immunotherapies
Michal J. Besser et al.
CLINICAL CANCER RESEARCH (2013)
Anti-PD-1 Antibody Therapy Potently Enhances the Eradication of Established Tumors By Gene-Modified T Cells
Liza B. John et al.
CLINICAL CANCER RESEARCH (2013)
A Single Peptide-Major Histocompatibility Complex Ligand Triggers Digital Cytokine Secretion in CD4+ T Cells
Jun Huang et al.
IMMUNITY (2013)
Transferred WT1-Reactive CD8+ T Cells Can Mediate Antileukemic Activity and Persist in Post-Transplant Patients
Aude G. Chapuis et al.
SCIENCE TRANSLATIONAL MEDICINE (2013)
Merkel cell polyomavirus: A newly discovered human virus with oncogenic potential
Megan E. Spurgeon et al.
VIROLOGY (2013)
Expression and prognostic relevance of PRAME in primary osteosarcoma
Pingxian Tan et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Challenges in T cell receptor gene therapy
Benjamin J. Uttenthal et al.
JOURNAL OF GENE MEDICINE (2012)
The blockade of immune checkpoints in cancer immunotherapy
Drew M. Pardoll
NATURE REVIEWS CANCER (2012)
High fludarabine exposure and relationship with treatment-related mortality after nonmyeloablative hematopoietic cell transplantation
J. R. Long-Boyle et al.
BONE MARROW TRANSPLANTATION (2011)
Durable Complete Responses in Heavily Pretreated Patients with Metastatic Melanoma Using T-Cell Transfer Immunotherapy
Steven A. Rosenberg et al.
CLINICAL CANCER RESEARCH (2011)
MAGE-A10 is a nuclear protein frequently expressed in high percentages of tumor cells in lung, skin and urothelial malignancies
Elke Schultz-Thater et al.
INTERNATIONAL JOURNAL OF CANCER (2011)
Contribution of IL-17-producing γδ T cells to the efficacy of anticancer chemotherapy
Yuting Ma et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
T Cells Targeting Carcinoembryonic Antigen Can Mediate Regression of Metastatic Colorectal Cancer but Induce Severe Transient Colitis
Maria R. Parkhurst et al.
MOLECULAR THERAPY (2011)
The Polycomb complex PRC2 and its mark in life
Raphael Margueron et al.
NATURE (2011)
Mechanisms for T cell receptor triggering
P. Anton van der Merwe et al.
NATURE REVIEWS IMMUNOLOGY (2011)
Towards a systems understanding of MHC class I and MHC class II antigen presentation
Jacques Neefjes et al.
NATURE REVIEWS IMMUNOLOGY (2011)
The Optimal Antigen Response of Chimeric Antigen Receptors Harboring the CD3ζ Transmembrane Domain Is Dependent upon Incorporation of the Receptor into the Endogenous TCR/CD3 Complex
John S. Bridgeman et al.
JOURNAL OF IMMUNOLOGY (2010)
MAGE-RING Protein Complexes Comprise a Family of E3 Ubiquitin Ligases
Jennifer M. Doyle et al.
MOLECULAR CELL (2010)
Lethal graft-versus-host disease in mouse models of T cell receptor gene therapy
Gavin M. Bendle et al.
NATURE MEDICINE (2010)
Gene therapy with human and mouse T-cell receptors mediates cancer regression and targets normal tissues expressing cognate antigen
Laura A. Johnson et al.
BLOOD (2009)
The Prioritization of Cancer Antigens: A National Cancer Institute Pilot Project for the Acceleration of Translational Research
Martin A. Cheever et al.
CLINICAL CANCER RESEARCH (2009)
High frequency of MAGE-A4 and MAGE-A9 expression in high-risk bladder cancer
Alain Bergeron et al.
INTERNATIONAL JOURNAL OF CANCER (2009)
Genetic modification of natural killer cells for adoptive cellular immunotherapy
Hollie J. Pegram et al.
IMMUNOTHERAPY (2009)
Adoptive Cell Therapy for Patients With Metastatic Melanoma: Evaluation of Intensive Myeloablative Chemoradiation Preparative Regimens
Mark E. Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Single and dual amino acid substitutions in TCR CDRs can enhance antigen-specific T cell functions
Paul F. Robbins et al.
JOURNAL OF IMMUNOLOGY (2008)
Effective tumor treatment targeting a melanoma/melanocyte-associated antigen triggers severe ocular autoimmunity
Douglas C. Palmer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Booster vaccination of cancer patients with MAGE-A3 protein reveals long-term immunological memory or tolerance depending on priming
Djordje Atanackovic et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
Different T cell receptor affinity thresholds and CD8 coreceptor dependence govern cytotoxic T lymphocyte activation and tetramer binding properties
Bruno Laugel et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
Increased intensity lymphodepletion and adoptive immunotherapy - how far can we go?
Pawel Muranski et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2006)
Cancer regression in patients after transfer of genetically engineered lymphocytes
Richard A. Morgan et al.
SCIENCE (2006)
Enhanced antitumor activity of murine-human hybrid T-cell receptor (TCR) in human lymphocytes is associated with improved pairing and TCR/CD3 stability
Cyrille J. Cohen et al.
CANCER RESEARCH (2006)
Cell therapy of stage IV nasopharyngeal carcinoma with autologous Epstein-Barr virus-targeted cytotoxic T lymphocytes
P Comoli et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Tumoral and immunologic response after vaccination of melanoma patients with an ALVAC virus encoding MAGE antigens recognized by T cells
N van Baren et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Licensing of natural killer cells by host major histocompatibility complex class I molecules
S Kim et al.
NATURE (2005)
Cancer/testis antigens, gametogenesis and cancer
AJG Simpson et al.
NATURE REVIEWS CANCER (2005)
Interaction between the CD8 coreceptor and major histocompatibility complex class I stabilizes T cell receptor-antigen complexes at the cell surface
L Wooldridge et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Adoptive cell transfer therapy following non-myeloablative but lymphodepleting chemotherapy for the treatment of patients with refractory metastatic melanoma
ME Dudley et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Sinks, suppressors and antigen presenters: how lymphodepletion enhances T cell-mediated tumor immunotherapy
CA Klebanoff et al.
TRENDS IN IMMUNOLOGY (2005)
NY-ESO-1 expression and immunogenicity in malignant and benign breast tumors
Y Sugita et al.
CANCER RESEARCH (2004)
MAGE-A8 overexpression in transitional cell carcinoma of the bladder: identification of two tumour-associated antigen peptides
E Bar-Haim et al.
BRITISH JOURNAL OF CANCER (2004)
The MHC class I antigen presentation pathway: strategies for viral immune evasion
EW Hewitt
IMMUNOLOGY (2003)
Tumor regression and autoimmunity after reversal of a functionally tolerant state of self-reactive CD8+ T cells
WW Overwijk et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2003)
Epidemiologic classification of human papillomavirus types associated with cervical cancer
N Muñoz et al.
NEW ENGLAND JOURNAL OF MEDICINE (2003)
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma:: In vivo persistence, migration, and antitumor effect of transferred T cells
C Yee et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2002)
Clinical pattern and therapeutic results achieved in 1490 patients with germ-cell tumours of the testis:: the experience of the Spanish Germ-Cell Cancer Group (GG)
JR Germà-Lluch et al.
EUROPEAN UROLOGY (2002)
Retargeting of natural killer-cell cytolytic activity to ErbB2-expressing cancer cells results in efficient and selective tumor cell destruction
C Uherek et al.
BLOOD (2002)
Mechanisms contributing to T cell receptor signaling and assembly revealed by the solution structure of an ectodomain fragment of the CD3εγ heterodimer
ZYJ Sun et al.
CELL (2001)
Evidence for a causal association between human papillomavirus and a subset of head and neck cancers
ML Gillison et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2000)
Share Paper
